Brief Report of Anti–Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC Therapy

In the recent past, we observed an increased risk of cancer in the population with human immunodeficiency virus (HIV) owing to the development of antiretroviral therapies that decreased mortality caused by HIV-specific infections. This particularly fragile population is frequently excluded from clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Bertin, Lise, Canellas, Anthony, Abbar, Baptiste, Veyri, Marianne, Spano, Jean-Philippe, Cadranel, Jacques, Lavolé, Armelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605183/
https://www.ncbi.nlm.nih.gov/pubmed/34825236
http://dx.doi.org/10.1016/j.jtocrr.2021.100247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605183/
https://www.ncbi.nlm.nih.gov/pubmed/34825236
http://dx.doi.org/10.1016/j.jtocrr.2021.100247

Ejemplares similares